论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
组蛋白乳酰化与疾病:中医药的调节作用及治疗意义
Received 20 February 2025
Accepted for publication 24 July 2025
Published 29 July 2025 Volume 2025:19 Pages 6435—6459
DOI https://doi.org/10.2147/DDDT.S524008
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Yan Zhu
Yuyue Qiu, Xiaoni Shao
College of Pharmacy and Food, Southwest Minzu University, Chengdu, Sichuan, 610225, People’s Republic of China
Correspondence: Xiaoni Shao, College of Pharmacy and Food, Southwest Minzu University, #168 Dajian Street, Shuangliu District, Chengdu, 610225, People’s Republic of China, Tel +86-28-85738423, Email xnshao@swun.edu.cn
Abstract: Histone lactylation, as a common post-translational modification (PTM), is crucial in diseases. Aberrant histone lactylation has been linked to disease pathogenesis, thus positioning it as a therapeutic target. This review summarizes the bidirectional relationship between histone lactylation and diseases, emphasizing how Traditional Chinese medicine (TCM) regulates lactate levels to restore histone lactylation homeostasis. Mechanistically, TCM modulates histone lactylation through dual regulation of lactyltransferases and lactate metabolism, thereby influencing disease progression in inflammatory, metabolic, and neoplastic disorders. Notably, TCM is characterized by unique advantages of cost-effectiveness, high efficacy, and minimal adverse effects. For diseases with established drug resistance, TCM offers a promising therapeutic alternative in managing drug-resistant illness by regulating histone lactylation. This review is conducive to understanding the relationship between histone lactylation and disease. TCM effectively treats diseases through the regulation of histone lactylation, thereby highlighting its potential for disease treatment application.
Keywords: histone lactylation, disease, Traditional Chinese medicine, mechanism, therapeutic target